Sale!

RAD51C Gene Breast-Ovarian Cancer Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RAD51C gene plays a critical role in DNA repair and maintaining genomic stability. Mutations in this gene have been associated with an increased risk of hereditary breast and ovarian cancer. The RAD51C Gene Breast-Ovarian Cancer Genetic Test is a specialized diagnostic tool designed to detect mutations in the RAD51C gene that could predispose individuals to these cancers. By identifying these genetic variations, the test can help in assessing an individual’s risk and inform more personalized prevention or treatment strategies.

Performed at DNA Labs UAE, this test is an essential resource for individuals with a family history of breast or ovarian cancer, offering a proactive approach to managing their health. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides. By opting for this test, individuals can take a significant step towards understanding their genetic risk and making informed decisions about their healthcare in collaboration with their medical providers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RAD51C Gene Breast-ovarian cancer Genetic Test

At DNA Labs UAE, we offer the RAD51C Gene Breast-ovarian cancer Genetic Test for individuals who want to assess their risk of developing breast and ovarian cancer. This test is designed to analyze the RAD51C gene, which plays a crucial role in DNA repair.

Test Components

The RAD51C Gene Breast-ovarian cancer Genetic Test includes:

  • NGS Technology

Price

The cost of the RAD51C Gene Breast-ovarian cancer Genetic Test is 4400.0 AED.

Sample Condition

You can provide a blood sample, extracted DNA, or one drop of blood on an FTA card for this test.

Report Delivery

The report for the RAD51C Gene Breast-ovarian cancer Genetic Test will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS (Next-Generation Sequencing) technology to analyze the RAD51C gene.

Test Type

The RAD51C Gene Breast-ovarian cancer Genetic Test is specifically designed for cancer detection.

Doctor

An oncologist will oversee the RAD51C Gene Breast-ovarian cancer Genetic Test.

Test Department

The test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the RAD51C Gene Breast-ovarian cancer Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by RAD51C Gene Breast-ovarian cancer NGS Genetic DNA Test gene RAD51C.

Test Details

The RAD51C gene is responsible for DNA repair. Mutations in this gene have been associated with an increased risk of developing breast and ovarian cancer. The NGS technology allows for the simultaneous sequencing of multiple genes, including RAD51C. By analyzing the genetic information obtained through NGS, healthcare professionals can determine if an individual carries any mutations in the RAD51C gene that may increase their susceptibility to breast and ovarian cancer. This information can be used to provide personalized risk assessments, genetic counseling, and potentially guide treatment decisions for individuals at high risk for these types of cancer.

Test Name RAD51C Gene Breast-ovarian cancer Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RAD51C Gene Breast-ovarian cancer NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RAD51C Gene Breast-ovarian cancer NGS Genetic DNA Test gene RAD51C
Test Details

The RAD51C gene is a gene that plays a crucial role in DNA repair. Mutations in this gene have been associated with an increased risk of developing breast and ovarian cancer.

NGS (Next-Generation Sequencing) is a genetic test that allows for the simultaneous sequencing of multiple genes, including the RAD51C gene. This test can identify any mutations or variations in the RAD51C gene that may increase an individual’s risk of developing breast and ovarian cancer.

By analyzing the genetic information obtained through NGS, healthcare professionals can determine if an individual carries any mutations in the RAD51C gene that may increase their susceptibility to breast and ovarian cancer. This information can be used to provide personalized risk assessments, genetic counseling, and potentially guide treatment decisions for individuals at high risk for these types of cancer.